Sciclone Pharmaceuticals, Inc. (SCLN) Tops Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts SCLN Hot Sheet
Price: $11.15 --0%
Financial Fact:
Promotion services: 1.09M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Promotion services: 1.09M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Sciclone Pharmaceuticals, Inc. (NASDAQ: SCLN) reported Q2 EPS of $0.13, $0.03 better than the analyst estimate of $0.10. Revenue for the quarter came in at $33.1 million versus the consensus estimate of $33.36 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
- Legence Corp. (LGN) Misses Q2 EPS by 58c
- Telesat Corporation (TSAT) Misses Q2 EPS by 1006c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
